UDICAD-150 contains Ursodeoxycholic Acid 150 mg, a hepatobiliary formulation used in selected cholestatic liver and biliary disorders. A focused PCD Pharma Hepatoprotective portfolio offering.
Selected cholestatic liver and gallbladder disorders.
No, treatment depends on the underlying diagnosis.
Use exactly as prescribed and follow liver-function monitoring where advised. Inform the physician about biliary obstruction, gallstones or other liver disorders.
Diarrhea, abdominal discomfort, nausea, constipation or headache may occur.
UDICAD-150: Ursodeoxycholic Acid reduces the intestinal absorption of cholesterol and improves bile composition and bile flow, supporting management of selected cholestatic and biliary disorders.
